MAPT and Alzheimer disease: Given the extensive literature demonstrating that palmitic acid induces post-translational modifications of tau in neurodegenerative diseases, including AD [23], we hypothesized that age-related increases in serum palmitoyl-L-carnitine influence tau phosphorylation in the brain.